BRIEF published on 08/19/2025 at 20:35, 3 months 16 days ago CannaPharmaRX Expands Global Cannabis Exports Revenue Forecast International Markets Production Expansion CannapharmaRx Cannabis Exports
PRESS RELEASE published on 08/19/2025 at 20:30, 3 months 16 days ago CannaPharmaRX Expands Cannabis Exports, Projects $1M+ Q3 Revenue CannaPharmaRX strengthens global cannabis presence with strategic developments, major shipments to Europe, expanding presence in Israel, scaling up production, and strong Q3 revenue forecast Revenue Forecast Global Presence Cannabis CannapharmaRx Exports
BRIEF published on 05/06/2025 at 20:35, 6 months 29 days ago CannaPharmaRx Expands into European Market with German Shipment German Market Cannabis Cultivation International Shipment Canadian Growers THC Pricing
PRESS RELEASE published on 05/06/2025 at 20:30, 6 months 29 days ago CannapharmaRx Continues into New European Market with First Shipment Completed to Germany CannaPharmaRX, Inc. provides updates on successful cannabis shipments to Israel and Germany, plans for future shipments, and ongoing cultivation activities Cannabis Germany CannapharmaRx Shipments Cultivation
BRIEF published on 12/03/2024 at 17:50, 1 year ago CannaPharmaRX Advances with Alberta Facility and International Expansion International Expansion Revenue Projections CannapharmaRx Alberta Facility Branded Products
PRESS RELEASE published on 12/03/2024 at 17:45, 1 year ago CannapharmaRX Updates on Alberta Facility Progress and International Export Strategy CannaPharmaRX, Inc. advances in cannabis production with new facility in Alberta, revenue projections, global exports, growth plans for 2025, new CEO search, and CTO engagement Revenue Projections CannapharmaRx Cannabis Production Global Exports New CEO Search
BRIEF published on 11/05/2024 at 19:25, 1 year ago CannaPharmaRx Advances with New Cannabis Shipment to Israel Revenue Growth International Expansion CannapharmaRx Cannabis Shipment Israel Market
PRESS RELEASE published on 11/05/2024 at 19:20, 1 year ago CannapharmaRx to Complete Additional Shipment in November CannaPharmaRX, Inc. reports continued progress at its cannabis facility in Cremona, Alberta. Recent shipments to Israel show growth potential. Expansion plans in Europe and globally Global Expansion Revenue Growth CannapharmaRx Cannabis Production Shipments To Israel
BRIEF published on 08/15/2024 at 19:00, 1 year 3 months ago CannaPharmaRx Receives Multiple Purchase Orders and Begins Delivery of Product International Expansion Medical Cannabis CannapharmaRx Cannabis Production Purchase Orders
PRESS RELEASE published on 08/15/2024 at 18:55, 1 year 3 months ago CannaPharmaRx Receives Multiple Purchase Orders and Begins Delivery of Product CannaPharmaRx, Inc. receives 600KG cannabis orders from Cantek Holdings, further solidifying its position in the cannabis market internationally. Continues high-quality production at Cremona facility International Markets CannapharmaRx Cantek Holdings Cannabis Orders Cremona Facility
Published on 12/05/2025 at 02:35, 4 hours 11 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 46 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 41 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 46 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 3 hours 16 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 56 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 21 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 31 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 36 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 12 hours 46 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 1 minute ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 13 hours 2 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 45 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago Declaration of voting rights at the end of November 2025
